Novogaia
Developing new medicines from fungi using AI.
Novogaia is decoding drug-like molecular structures from nature for novel medicines, starting with autoimmunity.
Founders
Tess Bevers
CEO
Tess is a biochemical engineer researching molecular dynamics and the origin of life at TU Delft and Imperial. She is an ex-Morgan Stanley IB, and worked in biotech ops at Newform Foods.
David Kubanek
CTO
David is a machine learning researcher from UCL and ETH Zurich, currently publishing with UCB Pharma on AI systems for molecule bioactivity prediction.